Pharmagene Overview
- Founded
-
2005
- Status
-
Public
- Employees
-
34
- Stock Symbol
-
7595
- Share Price
-
$0.46
- (As of Friday Closing)
Pharmagene General Information
Description
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.
Contact Information
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Stock Exchange
ROCO
Primary Office
- 4F., Number 17, Lane 171, Sector 2, Jiuzong Road
- Neihu District
- Taipei, 114
- Taiwan
+886 02 0000 0000
Pharmagene Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.46 | $0.47 | $0.45 - $0.87 | $19.8M | 43.5M | 31.6K | -$0.03 |
Pharmagene Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 22,949 | 25,071 | 32,841 | |
| Revenue | 4,420 | 4,629 | 3,443 | 2,112 |
| EBITDA | (710) | (320) | 94 | (848) |
| Net Income | (1,321) | (839) | (381) | (1,136) |
| Total Assets | 13,026 | 15,137 | 16,130 | 5,750 |
| Total Debt | 437 | 532 | 775 | 626 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pharmagene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pharmagene Patents
Pharmagene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20070298426-A1 | Warfarin dosage prediction | Inactive | 02-Jun-2006 | 0000000000 | |
| AU-2013219191-A1 | Hla alleles associated with adverse drug reactions and methods for detecting such | Inactive | 11-May-2006 | ||
| AU-2007249225-B2 | Hla alleles associated with adverse drug reactions and methods for detecting such | Active | 11-May-2006 | 0000000000 | |
| AU-2007249225-A1 | Hla alleles associated with adverse drug reactions and methods for detecting such | Active | 11-May-2006 | 0000000000 | |
| CA-2651954-C | Hla alleles associated with adverse drug reactions and methods for detecting such | Active | 11-May-2006 | C12Q1/6881 |
Pharmagene Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Sophia Jan | General Manager & Chief Executive Officer | ||
| Yuanchong Chen MD | Founder | ||
| Jin-Jer Chen | Chairman |
Pharmagene Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jin-Jer Chen | Pharmagene | Chairman | 000 0000 |
Pharmagene Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
